Home > Insider Trading > Filing (0001127602-19-031206)

Filing Details

Accession Number:: 0001127602-19-031206
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-10-29 16:42:36
Reporting Period:: 2019-10-25

Accepted Time:: 2019-10-29 16:42:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
97745	Thermo Fisher Scientific Inc.	TMO	Measuring & Controlling Devices, Nec (3829)	042209186

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1216055	N Marc Casper	168 Third Avenue Waltham MA 02451	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-10-25	47,729	$73.24	328,960	No	4	M	Direct
Common Stock	Disposition	2019-10-25	1,100	$291.36	327,860	No	4	S	Direct
Common Stock	Disposition	2019-10-25	3,080	$292.56	324,780	No	4	S	Direct
Common Stock	Disposition	2019-10-25	6,352	$293.50	318,428	No	4	S	Direct
Common Stock	Disposition	2019-10-25	3,400	$294.82	315,028	No	4	S	Direct
Common Stock	Disposition	2019-10-25	4,975	$295.69	310,053	No	4	S	Direct
Common Stock	Disposition	2019-10-25	15,955	$296.68	294,098	No	4	S	Direct
Common Stock	Disposition	2019-10-25	12,867	$297.59	281,231	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-10-25	47,729	$0.00	47,729	$73.24

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-02-26	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	69,330	Indirect	By Marc N. Casper 2012 Irrevocable Trust

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $291.02 to $291.85, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7) and (8) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.08 to $293.07, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.08 to $294.06, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $294.11 to $295.035, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.12 to $296.11, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $296.135 to $297.13, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $297.16 to $298.15, inclusive.
The option vested in four equal installments on February 26, 2014, 2015, 2016 and 2017.